Suchergebnisse - "Magro, F"

PubPharm (91)

1

Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases : an International Organization for Study of Inflammatory Bowel Diseases consensus

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Ananthakrishnan, A. | Kaplan, G. | Bernstein, C. | +103

2

ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology

enthalten in: Journal of Crohn's & colitis | 2022

von Magro, F. | Sabino, J. | Rosini, F. | +11

3

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2021

von Kucharzik, T. | Ellul, P. | Greuter, T. | +22

CommentIn: J Crohns Colitis. 2022 Jan 24;:. - PMID 35073577

4

Inflammatory Bowel Disease Management During the COVID-19 Outbreak : The Ten Do's and Don'ts from the ECCO-COVID Taskforce

enthalten in: Journal of Crohn's & colitis | 2020

von Magro, F. | Rahier, J. | Abreu, C. | +12

5

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients : Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

enthalten in: Journal of Crohn's & colitis | 2019

von Magro, F. | Lopes, S. | Silva, M. | +18

6

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Goncalves, J. | Santos, M. | Acurcio, R. | +29

CommentIn: Aliment Pharmacol Ther. 2018 Sep;48(5):574-575. - PMID 30156324

7

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease : Results from the Multicenter European TEDDY Study

enthalten in: The American journal of gastroenterology | 2018

von Chaparro, M. | Verreth, A. | Lobaton, T. | +61

CommentIn: Am J Gastroenterol. 2018 Dec;113(12):1903. - PMID 29895982

8

The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels

enthalten in: Therapeutic advances in gastroenterology | 2018

von Magro, F. | Rocha, C. | Vieira, A. | +6

9

Proactive therapeutic drug monitoring of infliximab : a comparative study of a new point-of-care quantitative test with two established ELISA assays

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Afonso, J. | Lopes, S. | Gonçalves, R. | +11

10

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

enthalten in: Journal of Crohn's & colitis | 2015

von Vegh, Z. | Burisch, J. | Pedersen, N. | +84

ErratumIn: J Crohns Colitis. 2015 Oct;9(10):939. - PMID 26417056

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]